Dr Lynn Theprungsirikul is a Senior Scientist in Upstream Process Development at AstraZeneca, where she focuses on cell culture process development, platform technologies, late stage development, and innovation initiatives that advance and modernize bioprocessing platforms.

Prior to joining AstraZeneca, Lynn conducted research at the University of California San Diego, where she contributed to the design and development of organ on a chip technologies that model cancer vascularization and cardiac microtissues for drug screening and development. She earned her PhD in Immunology and Microbiology from Dartmouth College and holds a Bachelor of Science in Biology from Duke University.